DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/0edf95/veterinary_vaccine) has announced the addition of the "Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms" report to their offering.
“Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms”
GBI Research, the leading business intelligence provider, has released its latest research, Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms. The report analyzes the markets for veterinary vaccines, covering bovine, ovine, porcine and equine species in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), and Japan. The report also provides geographical landscape, competitive landscape, product profiles, and analysis of drivers and barriers that impact the veterinary vaccines market. Furthermore, the report provides company profiling, SWOT analysis for the leading companies, and analysis of the mergers, acquisitions, recent activities and licensing agreements that shape the global markets.
The veterinary vaccines market has shown growth over recent years, which can be attributed to good animal husbandry practices and better management of farms. This results in the estimation of further growth in the market due to the advancement in biotechnological research and the tremendous development in the innovation of new vaccines for various diseases.
The Global Veterinary Vaccines Market Will Witness Consistent Growth with Europe to Continue to Dominate
The global veterinary vaccines market grew at the rate of 1% from 2002-2010, and is likely to witness the same growth for the period 2011-2017. The European veterinary vaccines market grew at a CAGR of 1% from 2002 to 2010. The total livestock vaccines market was estimated to be worth $2.9 billion in 2010, and is expected to grow at the same rate to reach $3.1 billion in 2017.
Companies Mentioned:
- Bayer HealthCare
- Pfizer
- Merck Inc.
- Novartis
For more information visit http://www.researchandmarkets.com/research/0edf95/veterinary_vaccine

